Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bull’s thesis on NVO. Novo Nordisk A/S's share was trading at $70.73 as of June 24^th. NVO’s trailing and forward P/E were 19.24 and 17.09, respectively, according to Yahoo Finance.

[caption id="attachment_1205351" align="aligncenter" width="768"] A picture of a pharma technician preparing an IV injection of a biopharmaceutical product.[/caption]

Novo Nordisk continues to solidify its leadership in obesity treatment with groundbreaking clinical...